Press Releases

Press Releases

  1. BTG licenses haemofiltration device patents to Fresenius Medical Care

  2. Results of European Phase III Randomised Controlled Trial Comparing Varisolve ® with Surgery or Sclerotherapy Published in Phlebology

  3. Genzyme reports Phase III data showing Campath® is superior to Chlorambucil as a first-line therapy in B-CLL

  4. BTG plc: Interim Results for the Six Months Ended 30 September 2006

  5. Strata Technology Partners Retained by BTG to Auction Rights to a Substantial OLED Patent Portfolio

  6. BTG Appoints Peter Chambré as Non-Executive Director

  7. BTG Completes Sale of RFID Patent Portfolio

  8. BTG Licensee TolerRx

  9. BTG Sells Online Navigation Tracking Patents

  10. BTG PLC: Notification of Major Interests in Shares

  11. BTG plc: 2006 AGM Statement

  12. BTG plc: Results of AGM

  13. BTG plc: Notification of Major Interests in Shares

  14. BTG PLC: Notification of Major Interests in Shares

  15. Annual Information Update 2006

  16. BTG PLC: Notification of Major Interests in Shares

  17. Directors' Interests in the Shares of BTG plc

  18. BTG PLC: Application to the London Stock Exchange

  19. Notification of Submission of Documents to the UK Listing Authority

  20. BTG to commence US phase II clinical safety study of Varisolve®

  21. Directors’ Interests in the Shares of BTG plc

  22. BTG PLC : Notification of Major Interests in Shares

  23. BTG reports preliminary results for the year ended 31 March 2006

  24. BTG plc: Notification Of Major Interests In Shares

  25. BTG plc: Close Period Update

  26. BTG Sells Teleshuttle Patent Rights To Twintech E.U.

  27. BTG PLC : Notification of Major Interests in Shares

  28. BTG Appoints Piper Jaffray as Joint Financial Adviser and Joint Broker

  29. BTG Grants QRSciences Option to Acquire NQR Patents

  30. BTG Licenses Alzheimer's Compounds To Senexis And Co-Invests £1 Million With The Wellcome Trust

  31. BTG Licenses Analgesic Compounds from Asterand